BioMarin Pharmaceutical (BMRN) News Today $58.27 +0.59 (+1.02%) Closing price 04:00 PM EasternExtended Trading$58.36 +0.09 (+0.15%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMRN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Jump Financial LLC Grows Position in BioMarin Pharmaceutical Inc. $BMRNAugust 29 at 5:19 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by BrokeragesAugust 29 at 2:21 AM | marketbeat.comOppenheimer Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)August 28 at 11:22 AM | theglobeandmail.comStrong Q2 Results and Pipeline Progress Could Be a Game Changer for BioMarin Pharmaceutical (BMRN)August 28 at 11:22 AM | finance.yahoo.comBioMarin Pharmaceutical Inc. $BMRN Stock Position Reduced by Corebridge Financial Inc.August 28 at 7:18 AM | marketbeat.comBioMarin Pharmaceutical Inc. $BMRN Shares Bought by APG Asset Management N.V.August 28 at 5:51 AM | marketbeat.comQuantbot Technologies LP Grows Position in BioMarin Pharmaceutical Inc. $BMRNAugust 28 at 4:41 AM | marketbeat.comBioMarin to Participate in Upcoming Investor ConferencesAugust 27 at 9:00 AM | prnewswire.comHsbc Holdings PLC Grows Position in BioMarin Pharmaceutical Inc. $BMRNAugust 26 at 4:16 AM | marketbeat.comNorthern Trust Corp Decreases Stock Position in BioMarin Pharmaceutical Inc. $BMRNAugust 26 at 4:05 AM | marketbeat.comBernstein Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN)August 25, 2025 | insidermonkey.comAlphaQuest LLC Increases Stake in BioMarin Pharmaceutical Inc. $BMRNAugust 25, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Decreases Holdings in BioMarin Pharmaceutical Inc. $BMRNAugust 25, 2025 | marketbeat.comKorea Investment CORP Has $15.19 Million Position in BioMarin Pharmaceutical Inc. $BMRNAugust 24, 2025 | marketbeat.comKaufman Rossin Wealth LLC Takes $461,000 Position in BioMarin Pharmaceutical Inc. $BMRNAugust 23, 2025 | marketbeat.comGroupama Asset Managment Sells 90,606 Shares of BioMarin Pharmaceutical Inc. $BMRNAugust 23, 2025 | marketbeat.comBarclays Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a PT of $86August 23, 2025 | msn.comCandriam S.C.A. Purchases 27,640 Shares of BioMarin Pharmaceutical Inc. $BMRNAugust 22, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Decreases Stock Holdings in BioMarin Pharmaceutical Inc. $BMRNAugust 22, 2025 | marketbeat.com836,397 Shares in BioMarin Pharmaceutical Inc. $BMRN Purchased by Fuller & Thaler Asset Management Inc.August 21, 2025 | marketbeat.comBernstein Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)August 20, 2025 | theglobeandmail.comAlgert Global LLC Boosts Stock Position in BioMarin Pharmaceutical Inc. $BMRNAugust 20, 2025 | marketbeat.comPrudential PLC Purchases New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 19, 2025 | marketbeat.comAberdeen Group plc Purchases 59,473 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 18, 2025 | marketbeat.comRussell Investments Group Ltd. Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 18, 2025 | marketbeat.comSector Gamma AS Sells 80,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 17, 2025 | marketbeat.comBioMarin (BMRN) Posts Strong Q2 Growth, Advances Rare Disease ResearchAugust 17, 2025 | msn.comFox Run Management L.L.C. Acquires 14,893 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 16, 2025 | marketbeat.comCallan Family Office LLC Purchases 12,304 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 14, 2025 | marketbeat.comForsta AP Fonden Has $2.24 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 14, 2025 | marketbeat.com9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.August 14, 2025 | marketbeat.comThe Top 5 Analyst Questions From BioMarin Pharmaceutical’s Q2 Earnings CallAugust 14, 2025 | msn.comBioMarin Announces Resignation of Chief Accounting OfficerAugust 13, 2025 | theglobeandmail.comEvercore ISI Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)August 13, 2025 | theglobeandmail.comSolid Earnings Reflect BioMarin Pharmaceutical's (NASDAQ:BMRN) Strength As A BusinessAugust 13, 2025 | finance.yahoo.comPersistent Asset Partners Ltd Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 13, 2025 | marketbeat.comNuveen LLC Acquires New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 13, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $11.72 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 13, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $108.32 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 13, 2025 | marketbeat.comBlair William & Co. IL Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 13, 2025 | marketbeat.comRefocused, deal-hungry drugmaker BioMarin pushes toward $4 billion revenue targetAugust 12, 2025 | bizjournals.comLeerink Partners Reiterates a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a PT of $105August 12, 2025 | msn.comASR Vermogensbeheer N.V. Purchases New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 12, 2025 | marketbeat.comVanguard Group Inc. Has $1.34 Billion Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 12, 2025 | marketbeat.comDeutsche Bank AG Cuts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 11, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.August 10, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded by Wall Street Zen to Strong-Buy RatingAugust 10, 2025 | marketbeat.comNatixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)August 9, 2025 | marketbeat.comBioMarin Pharmaceutical (BMRN) Gets a Buy from BMO CapitalAugust 8, 2025 | theglobeandmail.comBioMarin Pharmaceutical Inc. (BMRN) Stock forecastsAugust 8, 2025 | uk.finance.yahoo.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.421.03▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼1815▲BMRN Articles Average Week Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIIB News Today INCY News Today UTHR News Today NBIX News Today EXEL News Today MDGL News Today EXAS News Today HALO News Today RGEN News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access